Results for Erythroid Disorders

Share:
1 - 8 of 8
Stefano Rivella, PhD
Stefano Rivella

Dr. Rivella is an expert in the pathophysiology of erythroid and iron disorders and in the generation of lentiviral vectors for the cure of hemoglobinopathies. He also investigates additional disorders such as anemia of inflammation and hemochromatosis.

E-mail:
rivellas [at] chop.edu

ASCGT 26th Annual Meeting Well-Attended by CHOP Scientists

Published on
May 18, 2023
in Cornerstone Blog
ASCGT 26th Annual Meeting Well-Attended by CHOP Scientists
Scientists from Children’s Hospital of Philadelphia attend the American Society of Cell & Gene Therapy Annual Meeting to share their expertise through posters, panel discussions, and workshops.

In the News: RNA Innovation, Reducing Asthma Triggers, Early Autism Interventions

Published on
Apr 28, 2023
in Cornerstone Blog
In the News
Learn about the home renovations funded by CAPP+ to reduce asthma triggers and more in this week’s edition of In the News.

Scientific Symposium Gets to ‘Heart of Disease’ With Cell and Gene Therapy Talks

Published on
May 26, 2021
in Cornerstone Blog
17th Scientific Symposium Gets to ‘Heart of Disease’
The 17th Research Institute Scientific Symposium, held virtually on May 20, highlighted advances in cell and gene therapy.

2019 Distinguished Research Trainees Show Character and Creativity

Published on
Apr 11, 2019
in Cornerstone Blog
2019 Distinguished Research Trainees
Meet the four recipients of our 2019 Distinguished Research Trainee Awards at CHOP Research Institute.

Enzyme Identified as Possible Novel Drug Target for Sickle Cell Disease, Thalassemia

Published on
Jul 19, 2018
in Press Releases
CHOP, Penn Researchers: CRISPR Screening Reveals Signaling Protein with Key Role in Regulating Hemoglobin in Red Blood Cells

Rivella Laboratory Research Overview

The Rivella Lab is focused on the pathophysiology of erythroid and iron disorders and in the generation of lentiviral vectors for the cure of hemoglobinopathies.

About Rivella Laboratory

The Rivella Lab creates next-generation lentiviral vectors for the cure of hemoglobinopathies including sickle cell disease (SCD), as well as a leader in the discovery of erythroid and iron disorders including beta-thalassemia.

1 - 8 of 8